免疫組織学的、及びフローサイトメトリーによる再発髄膜腫の増殖能に関する研究

Saved in:
Bibliographic Details
Published inNeuro-Oncologyの進歩 Vol. 15; no. 1; pp. 39 - 46
Main Authors 李, 強, 河本, 圭司, 笠井, 治文, 大重, 英行, 我妻, 敬一, 山原, 崇弘, 沼, 義博, 龍, 尭志
Format Journal Article
LanguageJapanese
Published 近畿脳腫瘍病理検討会 2006
Online AccessGet full text
ISSN1880-0742
2187-0551
DOI10.11452/neurooncology2005.15.1_39

Cover

Author 李, 強
我妻, 敬一
沼, 義博
龍, 尭志
笠井, 治文
河本, 圭司
大重, 英行
山原, 崇弘
Author_xml – sequence: 1
  fullname: 李, 強
  organization: 関西医科大学 脳神経外科
– sequence: 1
  fullname: 河本, 圭司
  organization: 関西医科大学 脳神経外科
– sequence: 1
  fullname: 笠井, 治文
  organization: 関西医科大学 脳神経外科
– sequence: 1
  fullname: 大重, 英行
  organization: 関西医科大学 脳神経外科
– sequence: 1
  fullname: 我妻, 敬一
  organization: 関西医科大学 脳神経外科
– sequence: 1
  fullname: 山原, 崇弘
  organization: 関西医科大学 脳神経外科
– sequence: 1
  fullname: 沼, 義博
  organization: 関西医科大学 脳神経外科
– sequence: 1
  fullname: 龍, 尭志
  organization: 関西医科大学 脳神経外科
BookMark eNplkM1Kw0AAhBepYK19Ce-pu5vsJjlK8ZeCFz2HTUxqQ00kqYfeTFNLUYqXWql40CKChvYiFRR9miWmfQtTFS_CMAPDxxxmEWQc1zEBWEawgJBE8IpjHnuu6xhu1S3XMYSkgFJpojoHshgpsgAJQRmQRYoCBShLeAHkfd-GECKsUAnLWeDGp52kFyXjZvLajYcPyXWTnwTxxRkPnnl4ycMhD995Y8wb9zxs8_Du259mZRDxRps3zuNWJ-m_TaPmpHUzOY14MIoHV5-j3iT8SJlpb8CDfoolt93k8WUJzFus6pv538yBvfW13eKmUNrZ2CqulgQbiyoUdGqKDFJzX6XYUBSCMNEJpaqEGLGgJUOD6pDoli5STAiVCVOxolNdUqAq6QYSc2D7Z9f2a6xsakde5ZB5dY15tYpRNbV_12ko1cxE9Q8yDpin2Uz8Asullak
ContentType Journal Article
Copyright 近畿脳腫瘍病理検討会
Copyright_xml – notice: 近畿脳腫瘍病理検討会
DOI 10.11452/neurooncology2005.15.1_39
DeliveryMethod fulltext_linktorsrc
EISSN 2187-0551
EndPage 46
ExternalDocumentID article_neurooncology2005_15_1_15_39_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
JSH
KQ8
RJT
RZJ
ID FETCH-LOGICAL-j2390-b6e3a06ed962c885125b566941a5f0f70c6b05bfb36255675a928b6b48094bc13
ISSN 1880-0742
IngestDate Wed Sep 03 06:18:17 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 1
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2390-b6e3a06ed962c885125b566941a5f0f70c6b05bfb36255675a928b6b48094bc13
OpenAccessLink https://www.jstage.jst.go.jp/article/neurooncology2005/15/1/15_39/_article/-char/ja
PageCount 8
ParticipantIDs jstage_primary_article_neurooncology2005_15_1_15_39_article_char_ja
PublicationCentury 2000
PublicationDate 20060000
PublicationDateYYYYMMDD 2006-01-01
PublicationDate_xml – year: 2006
  text: 20060000
PublicationDecade 2000
PublicationTitle Neuro-Oncologyの進歩
PublicationTitleAlternate Neuro-Oncologyの進歩
PublicationYear 2006
Publisher 近畿脳腫瘍病理検討会
Publisher_xml – name: 近畿脳腫瘍病理検討会
References 16)中塚博貴, 大上史朗, 大田信介, 他: 初回手術より4ヶ月の経過で悪性転化した髄膜種の一例: 脳神経外科31: 2, 181-186, 2003
19) Chen 0, Demirhan B, Altinors N: Correlation between histological grade and MIB-1 and p53immunoreactivity in meningiomas.: Clin Neuropathol: 219-24, 2005
4) Bouvier C, Liprandi A, Colin C: Lack of alkaline phosphatase activity predicts meningioma recurrence: Am H Clin Pathol: 252-8, 2005
20) Roggendort W, Schuster T, Peiffer j: potential of meningiomas determined with the monoclonal antibody Ki-67. Acta Neuropathol(Berl) 73: 361-364, 1987.
14) Moller ML, Braendstrup 0: No prediction of recurrence of menigiomas by PCNA and Ki-6 7immunohistochemistry.: J Neurooncol. 34, 241-246, 1997
23) Trop SH, Lindboe CF, Gronberg BH, et al; Prognostic significance of Ki-67/MIB-1proliferation index in meningiomas: Clin Neuropathol. 24: 170-174, 2005
3) Bigner DD, McLendon RE, Bruner JM: Russell and Rubinstein's Pathology of Tumors of the Nervous System, 6th ed, Vol 2. London, Edw a rd Arnold: 69-122. 1998
15)森下暁二, 近藤威, 江原一雅, 他; 進行性にMIB-1 LIの上昇を示したpapillary meningiomaの一例:脳神経外科ジャーナル11: 8, 530-535, 2002
25)横山雅人, 荒井篤, 吉原育男, 他: 全摘出(Simpson gradeI)後, 二度の再発, 再手徳を繰り返した髄膜種の一例: 兵庫県立成人病センター紀要(0913-0927)18巻, p1-6(2004. 02
9) Kolles H, Niedermayer I, Schmitt C, et: Triple approach for diagnosisa nd grading of meningio mas: Histology, morphometry or Ki-67/Feulge n s taings, and cytgogenetics. Acta Neurochir(Wien) 137:174-181, 1995
17)西村俊直, 清弘真弓, 梅田泰司; 髄膜種の悪性度における細胞増殖能及び癌抑制遺伝子p53の検討: 山口臨技26: 3, 1-3, 2002
6)河本圭司, 李強, 我妻敬一, 他: 脳腫瘍の診断と治療: 日本臨床63巻増刊号9, 105-109, 2005
5) Kalala JP, Maes L, Vandenbrec ke C, et al The hTERT protein as a marker for malignanc y in meningiomas: Oncol Rep: 273-7, 2005
7)河本圭司, 他(編): 応用サイトメトリー, 医学書院, 2000.
10) Lamszus K: Meningioma pathology, genetics, and biology: J Neuropahol Exp Neurol 63: 2 75-286, 2004
24) Tyagi A, Chakrabarty A, Franks A; MIB-1proliferation index in meningiomas: does it predict recurrence?A clinicopathological study.: Br J Neurosurg. 18: 357-361, 2004
8)香城孝麿, 小保内主税: 術後再発を繰り返した髄膜種の1例: 道南医学会誌39号p253-255(2004,04
12) Maes L, Lippens E, Kalala JP, et al: The hTERT-proteina nd Ki-67 labellingi ndex in recurrent and non-recurrent meningiomas: Cell Prolif.: 3-12, 2005
13) Maier H, Wanschitz J, Sedivy R, et al: Proliferation and DNA fragmentation in meningiom a subtypes. Neuropathol Appl Neurobiol 77: 616-623, 1992
1 ) Akutsu H, Sugita K, Sonobe M, et aL: Parasagittal meningioma en plaque with extracranial extension presenting diffusemassive hyperostosis of the skull. Surg Neurol. 61: 165-169, 2004
18)脳腫瘍全国統計委員会, 日本病理学会編: 臨床・病理脳腫瘍取り扱い規約: 臨床と病理カラーアトラス. 東京, 金原出版, 2002
2)我姿敬一, 龍尭志, 大重英行, 他: 頭蓋骨外進展を認めた髄膜種の浸潤能についての検討: Neuro-Oncologyの進歩14: 30-37, 2005
21) Takeuchi H, Kubota T, Kabuto M, et at Prediction of recurrence in histologically benign meningiomas: Proliferating cell nuclear antigen and Ki-67 immunohistochemica study. Surg Neurol 48: 501-506, 1997
11) Louis DN, Scheithauer BW, Budka H, et al: MeningealT umors. Pathology and Genetics of Tumors of the Nervous System( World Health Organ i zation Classification of Tumors). Lyon, IARC, 2000, 75-184
22)谷川原徹哉, 佐藤由貴子, 山川春樹, 他: 再発をくりかえした側脳室三角部髄膜種の一例: 岐阜県立岐阜病院年報24, 73-77, 2003
References_xml – reference: 23) Trop SH, Lindboe CF, Gronberg BH, et al; Prognostic significance of Ki-67/MIB-1proliferation index in meningiomas: Clin Neuropathol. 24: 170-174, 2005
– reference: 18)脳腫瘍全国統計委員会, 日本病理学会編: 臨床・病理脳腫瘍取り扱い規約: 臨床と病理カラーアトラス. 東京, 金原出版, 2002,
– reference: 21) Takeuchi H, Kubota T, Kabuto M, et at Prediction of recurrence in histologically benign meningiomas: Proliferating cell nuclear antigen and Ki-67 immunohistochemica study. Surg Neurol 48: 501-506, 1997
– reference: 2)我姿敬一, 龍尭志, 大重英行, 他: 頭蓋骨外進展を認めた髄膜種の浸潤能についての検討: Neuro-Oncologyの進歩14: 30-37, 2005
– reference: 1 ) Akutsu H, Sugita K, Sonobe M, et aL: Parasagittal meningioma en plaque with extracranial extension presenting diffusemassive hyperostosis of the skull. Surg Neurol. 61: 165-169, 2004
– reference: 15)森下暁二, 近藤威, 江原一雅, 他; 進行性にMIB-1 LIの上昇を示したpapillary meningiomaの一例:脳神経外科ジャーナル11: 8, 530-535, 2002
– reference: 7)河本圭司, 他(編): 応用サイトメトリー, 医学書院, 2000.
– reference: 25)横山雅人, 荒井篤, 吉原育男, 他: 全摘出(Simpson gradeI)後, 二度の再発, 再手徳を繰り返した髄膜種の一例: 兵庫県立成人病センター紀要(0913-0927)18巻, p1-6(2004. 02)
– reference: 6)河本圭司, 李強, 我妻敬一, 他: 脳腫瘍の診断と治療: 日本臨床63巻増刊号9, 105-109, 2005
– reference: 11) Louis DN, Scheithauer BW, Budka H, et al: MeningealT umors. Pathology and Genetics of Tumors of the Nervous System( World Health Organ i zation Classification of Tumors). Lyon, IARC, 2000, 75-184
– reference: 12) Maes L, Lippens E, Kalala JP, et al: The hTERT-proteina nd Ki-67 labellingi ndex in recurrent and non-recurrent meningiomas: Cell Prolif.: 3-12, 2005
– reference: 19) Chen 0, Demirhan B, Altinors N: Correlation between histological grade and MIB-1 and p53immunoreactivity in meningiomas.: Clin Neuropathol: 219-24, 2005
– reference: 20) Roggendort W, Schuster T, Peiffer j: potential of meningiomas determined with the monoclonal antibody Ki-67. Acta Neuropathol(Berl) 73: 361-364, 1987.
– reference: 16)中塚博貴, 大上史朗, 大田信介, 他: 初回手術より4ヶ月の経過で悪性転化した髄膜種の一例: 脳神経外科31: 2, 181-186, 2003
– reference: 22)谷川原徹哉, 佐藤由貴子, 山川春樹, 他: 再発をくりかえした側脳室三角部髄膜種の一例: 岐阜県立岐阜病院年報24, 73-77, 2003
– reference: 10) Lamszus K: Meningioma pathology, genetics, and biology: J Neuropahol Exp Neurol 63: 2 75-286, 2004
– reference: 13) Maier H, Wanschitz J, Sedivy R, et al: Proliferation and DNA fragmentation in meningiom a subtypes. Neuropathol Appl Neurobiol 77: 616-623, 1992
– reference: 5) Kalala JP, Maes L, Vandenbrec ke C, et al The hTERT protein as a marker for malignanc y in meningiomas: Oncol Rep: 273-7, 2005
– reference: 3) Bigner DD, McLendon RE, Bruner JM: Russell and Rubinstein's Pathology of Tumors of the Nervous System, 6th ed, Vol 2. London, Edw a rd Arnold: 69-122. 1998
– reference: 8)香城孝麿, 小保内主税: 術後再発を繰り返した髄膜種の1例: 道南医学会誌39号p253-255(2004,04)
– reference: 14) Moller ML, Braendstrup 0: No prediction of recurrence of menigiomas by PCNA and Ki-6 7immunohistochemistry.: J Neurooncol. 34, 241-246, 1997
– reference: 9) Kolles H, Niedermayer I, Schmitt C, et: Triple approach for diagnosisa nd grading of meningio mas: Histology, morphometry or Ki-67/Feulge n s taings, and cytgogenetics. Acta Neurochir(Wien) 137:174-181, 1995
– reference: 17)西村俊直, 清弘真弓, 梅田泰司; 髄膜種の悪性度における細胞増殖能及び癌抑制遺伝子p53の検討: 山口臨技26: 3, 1-3, 2002
– reference: 4) Bouvier C, Liprandi A, Colin C: Lack of alkaline phosphatase activity predicts meningioma recurrence: Am H Clin Pathol: 252-8, 2005
– reference: 24) Tyagi A, Chakrabarty A, Franks A; MIB-1proliferation index in meningiomas: does it predict recurrence?A clinicopathological study.: Br J Neurosurg. 18: 357-361, 2004
SSID ssj0001286427
Score 1.4137162
SourceID jstage
SourceType Publisher
StartPage 39
Title 免疫組織学的、及びフローサイトメトリーによる再発髄膜腫の増殖能に関する研究
URI https://www.jstage.jst.go.jp/article/neurooncology2005/15/1/15_39/_article/-char/ja
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Neuro-Oncologyの進歩, 2006, Vol.15(1), pp.39-46
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na9RQEA-lXryIouI3PfiO0Xy9r2Oyu7UoKkILvS2bbPawh1akvfTk7ralKMVLrVQ8aBFBl_YiFRT9a8Ka9r9wZpLspqyCFiEbZufNzJs3vyTvzePlxTBuhqFo8hjSVNlS3IQePzZD2xGmdAWHn6ea9Dmf-w_EzJx3d57PT0zeKa1aWl4Kb0Urv32v5CSoAg9wxbdk_wHZoVFgAA34whkQhvNfYcxqnCk4qqwmmRbMD5AIgOMRoZn2UMavMl-QjE9FLq5vUDapTzPlE8dmgUuEyzTPCVDMiKBChIPGM8L38iKlCmF7jOMfV7fJQ1LPZYAIyA1RtEKzALQ0SqKrCot0hQheqIOdGrXLYVqymsC_0HyUgbqqpbo0hcXJOWB8VKlkvkXxAQIqFeVhOm1ZYj5ciLJ3eUZ1aoxc4FCdENThLAoydJUpWluKrkGLA1kuBSWMLzXGrxRi-Kea4xCokbxEGfCv5mE4AA-Sz6wEZAUCVrLPEQ9fkoMSQ0nyChsa2EgAOKpyfIpneDtieTDNtE0AcKRR1SOHh3GHIlWAJJGJhIXwYDC8HCRfYRDQ7QpcbaUuD57gJs6QZCMC4sG4T5oWz7cCLvpJPvY8yDq9bDeqfPiUTSiPd8wep51-Eb7FHD2a0LThqBcWjm18nt9W9TGdug0HnlxdL4TwHcV6GxKlU46UNq7tvfdIlSZbFeTZ9KGlorX5BsTo1-0_egXD0jYkacUCTxpzzp41zuTJ4pSf1X7OmGg3zhuLg7XNdLufHqymX7cGex_S16vJ087gxbOk8znpvUx6e0nve9I9SLrvk95G0ntH50_I7PST7kbSfT5Y30x3vh31Vw_X3xyu9ZPO_mD31c_97cPeD5A52t5NOjsglr7dSj9-uWDMTddmKzNm_tkUs-242jJDEbsNS8RNLZxIQUbl8BCSNu3ZDd6yWtKKRGjxsBXC2JVzIXlDOyoUoacs7YWR7V40JhcWF-JLxpSKMJ1zZVPgZ4kgl7Fibak4jtxY2y0rumxUsvjUH2d749RPAtqV_2LlqnF6ND16zZhcerIcX4eEYSm8QRfDL8da8nw
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E5%85%8D%E7%96%AB%E7%B5%84%E7%B9%94%E5%AD%A6%E7%9A%84%E3%80%81%E5%8F%8A%E3%81%B3%E3%83%95%E3%83%AD%E3%83%BC%E3%82%B5%E3%82%A4%E3%83%88%E3%83%A1%E3%83%88%E3%83%AA%E3%83%BC%E3%81%AB%E3%82%88%E3%82%8B%E5%86%8D%E7%99%BA%E9%AB%84%E8%86%9C%E8%85%AB%E3%81%AE%E5%A2%97%E6%AE%96%E8%83%BD%E3%81%AB%E9%96%A2%E3%81%99%E3%82%8B%E7%A0%94%E7%A9%B6&rft.jtitle=Neuro-Oncology%E3%81%AE%E9%80%B2%E6%AD%A9&rft.au=%E6%9D%8E%2C+%E5%BC%B7&rft.au=%E6%B2%B3%E6%9C%AC%2C+%E5%9C%AD%E5%8F%B8&rft.au=%E7%AC%A0%E4%BA%95%2C+%E6%B2%BB%E6%96%87&rft.au=%E5%A4%A7%E9%87%8D%2C+%E8%8B%B1%E8%A1%8C&rft.date=2006&rft.pub=%E8%BF%91%E7%95%BF%E8%84%B3%E8%85%AB%E7%98%8D%E7%97%85%E7%90%86%E6%A4%9C%E8%A8%8E%E4%BC%9A&rft.issn=1880-0742&rft.eissn=2187-0551&rft.volume=15&rft.issue=1&rft.spage=39&rft.epage=46&rft_id=info:doi/10.11452%2Fneurooncology2005.15.1_39&rft.externalDocID=article_neurooncology2005_15_1_15_39_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1880-0742&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1880-0742&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1880-0742&client=summon